Clinical Trials Browser

Unknown × Kenny-Caffey syndrome, Type 1 × Clear all

NCT05732129 2023-02-24

The Efficacy and Safety of Fluzoparib Plus Irinotecan as Second-line Treatment in Patients With Homologous Recombination Deficiency (HRD) Metastatic Colorectal Cancer.

Phase 2 Unknown

Kenny-Caffey syndrome, Type 1

NCT05044091 2021-09-14

HOPEI

Kenny-Caffey syndrome, Type 1, Ovarian Neoplasms